Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Myelodysplastic syndrome with excess blasts
ADR ID BADD_A10460
ADR Hierarchy
01      Blood and lymphatic system disorders
01.10      Leukaemias
01.10.04      Myelodysplastic syndromes
01.10.04.010      Myelodysplastic syndrome with excess blasts
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.01      Leukaemias
16.01.04      Myelodysplastic syndromes
16.01.04.010      Myelodysplastic syndrome with excess blasts
Description Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells. [MeSH]
MedDRA Code 10088023
MeSH ID D000754
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
RAEB | Refractory anaemia with an excess of blasts | Refractory anemia with an excess of blasts | Myelodysplastic syndrome with excess blasts | Myelodysplastic syndrome with excess blasts 2 | Myelodysplastic syndrome with excess blasts 1 | Anemia, Refractory, with Excess of Blasts | Leukemia, Smouldering | Smouldering Leukemia | RAEM | Refractory Anemia with Excess of Blasts | Leukemia, Smoldering | Leukemias, Smoldering | Smoldering Leukemia | Smoldering Leukemias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00194Azacitidine0.000112%
BADD_D00349Capecitabine0.000112%
BADD_D00560Cytarabine0.000112%
BADD_D01136Imatinib0.000112%
BADD_D01253Lenalidomide0.001133%
BADD_D01601Olaparib0.000112%
BADD_D02007Semaxanib--
The 1th Page    1    Total 1 Pages